Cleveland Biolabs Inc (NASDAQ:CBLI)

2.82
Delayed Data
As of 2:25pm ET
 +0.0356 / +1.28%
Today’s Change
2.24
Today|||52-Week Range
4.36
-29.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues3.7M2.7M3.5M1.9M
 
 
 
 
 
Depreciation And Amortization841.0K140.1K63.5K21.1K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses17.2M13.4M9.8M7.5M
 
 
 
 
 
Other Operating Expenses0.001.1M0.000.00
 
 
Research And Development9.6M7.1M6.5M5.0M
 
 
 
 
 
Total Operating Expenses18.1M14.6M9.9M7.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.4M-11.9M-6.4M-5.6M
 
 
 
 
 
Extraordinary Credit2.7M0.003.1M0.00
 
 
 
Extraordinary Charge-33.1K-221.9K0.00-4.4M
 
 
 
 
Pre-Tax Equity Earnings-285.5K-362.1K0.000.00
 
 
 
Interest Expense On Debt1.1M99.5K----
 
 
 
Other Expenses13.2M-509.5K402.7K-13.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income35.4K-13.0M-2.6M-9.8M
 
 
 
 
 
Minority Interest-1.6M-407.3K-68.8K-136.2K
 
 
 
 
 
Net Income1.6M-12.6M-2.7M-9.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M7.1M11.0M11.2M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M7.1M11.0M11.2M
 
 
 
 
 
 
Earnings Per ShareEPS$12.00-$1.79-$0.24-$0.87
 
 
 
 
 
EPS Diluted$0.60-$1.79-$0.24-$0.87